Medtronic Announces Voluntary Recall of Diabetes Infusion Sets

Silver Spring, Maryland–(ENEWSPF)–September 12, 2017. Medtronic plc (NYSE:MDT) announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models of Medtronic insulin pumps. The recall is related to a certain discontinued component in these infusion sets and does not include insulin pumps or glucose sensors. The company determined, through recent field reports from patients and root cause analysis, that a…